Home > Publications database > Cutaneous findings following COVID-19 vaccination: Review of world literature and own experience. > print

001     177084
005     20240229133731.0
024 7 _ |a pmid:34661927
|2 pmid
024 7 _ |a 0926-9959
|2 ISSN
024 7 _ |a 1468-3083
|2 ISSN
024 7 _ |a doi: 10.1111/jdv.17744
|2 doi
024 7 _ |a altmetric:115409317
|2 altmetric
037 _ _ |a DKFZ-2021-02290
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Gambichler, Thilo
|b 0
245 _ _ |a Cutaneous findings following COVID-19 vaccination: Review of world literature and own experience.
260 _ _ |a Oxford [u.a.]
|c 2022
|b Wiley-Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1642494051_16197
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Feb;36(2):172-180
520 _ _ |a There is growing evidence that not only the novel coronavirus disease (COVID-19) but also the COVID-19 vaccines can cause a variety of skin reactions. In this review article, we provide a brief overview on cutaneous findings that have been observed since the emerging mass COVID-19 vaccination campaigns all over the world. Unspecific injection site reactions very early occurring after the vaccination are most frequent. Type I hypersensitivity reactions (e.g., urticaria, angioedema, anaphylaxis) likely due to allergy to ingredients may rarely occur but can be severe. Type IV hypersensitivity reactions may be observed, including delayed large local skin lesions ('COVID arm'), inflammatory reactions in dermal filler or previous radiation sites or even old BCG scars, and more commonly moribilliform and erythema multiforme-like rashes. Autoimmune-mediated skin findings after COVID-19 vaccination include leukocytoclastic vasculitis, lupus erythematosus, and immune thrombocytopenia. Functional angiopathies (chilblain-like lesions, erythromelalgia) may also be observed. Pityriasis rosea-like rashes and reactivation of herpes zoster have also been reported after COVID-19 vaccination. In conclusion, there are numerous cutaneous reaction patterns that may occur following COVID-19 vaccination, whereby many of these skin findings are of immunological/autoimmunological nature. Importantly, molecular mimicry exists between SARS-CoV-2 (e.g., the spike-protein sequences used to design the vaccines) and human components and may thus explain some COVID-19 pathologies as well adverse skin reactions to COVID-19 vaccinations.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a COVID-19
|2 Other
650 _ 7 |a SARS-CoV-2
|2 Other
650 _ 7 |a adverse events
|2 Other
650 _ 7 |a coronavirus
|2 Other
650 _ 7 |a cutaneous reactions
|2 Other
650 _ 7 |a molecular mimicry
|2 Other
650 _ 7 |a side-effects
|2 Other
650 _ 7 |a skin
|2 Other
650 _ 7 |a vaccination
|2 Other
650 _ 7 |a vaccine
|2 Other
700 1 _ |a Boms, Stefanie
|b 1
700 1 _ |a Susok, Laura
|b 2
700 1 _ |a Dickel, Heinrich
|b 3
700 1 _ |a Finis, Cansu
|b 4
700 1 _ |a Abu Rached, Nessr
|b 5
700 1 _ |a Barras, Milan
|b 6
700 1 _ |a Stücker, Markus
|b 7
700 1 _ |a Kasakovski, Dimitri
|0 P:(DE-He78)a9aa7740c4c6f243d651d9bd35ed7fdf
|b 8
|e Last author
|u dkfz
773 _ _ |a 10.1111/jdv.17744
|0 PERI:(DE-600)2022088-1
|n 2
|p 172-180
|t Journal of the European Academy of Dermatology and Venereology
|v 36
|y 2022
|x 0926-9959
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177084
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)a9aa7740c4c6f243d651d9bd35ed7fdf
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2021
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-01-26
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-26
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-11
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-11
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EUR ACAD DERMATOL : 2021
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-11
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-11
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J EUR ACAD DERMATOL : 2021
|d 2022-11-11
920 1 _ |0 I:(DE-He78)A190-20160331
|k A190
|l A190 Vaskuläre Onkologie und Metastasierung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A190-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21